Mark Cuban challenges the idea that high drug prices are necessary for R&D, PBMs take away from profits, leaving less for ...

Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in the pharmacy benefit management ...

Cigna beat Wall Street estimate for second-quarter profit on Thursday, helped by strength in its pharmacy benefit management ...

But overall, we would not be surprised to see CVS continue in that pattern of leverage-increasing acquisitions, deleveraging by constraining other capital-allocation activities, hitting its leverage ...

Revenue from Cigna's pharmacy benefit management business rose 17% to $57.83 billion during the 2nd quarter of 2025.

The American Medical Association’s research, which found that local PBM markets are highly concentrated, is more fuel for ...

Cigna is reporting better-than-expected second earnings today, fueled in part by the strong performance of its pharmacy benefit management business.